DiscoverNew Retina Radio by EyetubeFrom Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME
From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME

From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME

Update: 2024-07-11
Share

Description

One of the challenges associated with current anti-VEGF therapies for the management of DME is the need for frequent injections and the potential impact on adherence and vision outcomes. Join Dr. John Kitchens and Dr. Maria Berrocal as they share their experiences treating their DME patients using a therapy with a novel mechanism of action, and how those patient outcomes have influenced their extension decisions and treatment management approaches. This special episode of New Retina Radio, and its content, is supported by Genentech USA, Inc. 

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME

From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME

Retina Today

We and our partners use cookies to personalize your experience, to show you ads based on your interests, and for measurement and analytics purposes. By using our website and our services, you agree to our use of cookies as described in our Cookie Policy.